Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People

“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention. ”

The fully captioned video and edited transcript will be posted within the next few days.

alert icon

This COCA Call will be held on Friday, March 27, 2020


The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Monoclonal antibodies may be available through expanded access programs to treat COVID-19 for immunocompromised patients. However, the efficacy of use for immunocompromised patients is unclear.

During this COCA Call, presenters will discuss the FDA’s role in issuing EUAs for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.


Elliot Raizes, MD
Task Force Lead
Health Services and Worker Safety Task Force
COVID-19 Response
Centers for Disease Control​ and Prevention

John Farley, MD, MPH
Director, Office of Infectious Diseases
Center for Drug Evaluation and Research
Office of New Drugs
U.S. Food and Drug Administration

Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention

Rajesh Gandhi, MD
Director, HIV Clinical Services and Education, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School

Adi V. Gundlapalli, MD, PhD
Co-Lead, Serology and Correlates of Protection Tiger Team, COVID-19 Response
Chief Public Health Informatics Officer
Center for Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention

Facebook Live icon

Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.

Call Details

Thursday, August 12, 2021,
2:00 PM – 3:00 PM ET

Webinar Link: icon

Passcode: 980771

Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373

International numbersexternal icon

One-tap mobile:
US: +16692545252,,1612254638#,,,,*980771#  or +16468287666,,1612254638#,,,,*980771#

Webinar ID: 161 225 4638

Add to Calendar
Sign up for COCA Newsletters and Announcements

Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address:

Page last reviewed: September 4, 2020